Correlation Between Visa and XTANT MEDICAL
Can any of the company-specific risk be diversified away by investing in both Visa and XTANT MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and XTANT MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and XTANT MEDICAL HLDGS, you can compare the effects of market volatilities on Visa and XTANT MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of XTANT MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and XTANT MEDICAL.
Diversification Opportunities for Visa and XTANT MEDICAL
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and XTANT is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and XTANT MEDICAL HLDGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTANT MEDICAL HLDGS and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with XTANT MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTANT MEDICAL HLDGS has no effect on the direction of Visa i.e., Visa and XTANT MEDICAL go up and down completely randomly.
Pair Corralation between Visa and XTANT MEDICAL
Taking into account the 90-day investment horizon Visa is expected to generate 1.17 times less return on investment than XTANT MEDICAL. But when comparing it to its historical volatility, Visa Class A is 5.06 times less risky than XTANT MEDICAL. It trades about 0.07 of its potential returns per unit of risk. XTANT MEDICAL HLDGS is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 54.00 in XTANT MEDICAL HLDGS on October 13, 2024 and sell it today you would lose (11.00) from holding XTANT MEDICAL HLDGS or give up 20.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.0% |
| Values | Daily Returns |
Visa Class A vs. XTANT MEDICAL HLDGS
Performance |
| Timeline |
| Visa Class A |
| XTANT MEDICAL HLDGS |
Visa and XTANT MEDICAL Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and XTANT MEDICAL
The main advantage of trading using opposite Visa and XTANT MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, XTANT MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will offset losses from the drop in XTANT MEDICAL's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| XTANT MEDICAL vs. Japan Asia Investment | XTANT MEDICAL vs. CHRYSALIS INVESTMENTS LTD | XTANT MEDICAL vs. Guangdong Investment Limited | XTANT MEDICAL vs. Cal Maine Foods |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |